Morpheaform basal cell carcinoma

Summary

Morpheaform basal cell carcinoma (MONDO:0002949) is a cancer and 1 clinical trial. A subtype of skin basal cell carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	morpheaform basal cell carcinoma
Mondo ID	MONDO:0002949
DOID	DOID:4292
NCIT	C27182
SNOMED CT	403913006
UMLS	C0555191
MedGen	107825
Is cancer (heuristic)	yes

Also known as: basal cell carcinoma sclerosing type · morphea-type (sclerosing) basal cell carcinoma · morphea-type basal cell carcinoma · morpheaform basal cell carcinoma · sclerosing type basal cell carcinoma · skin morphea-type (sclerosing) basal cell carcinoma

Disease family

This is a subtype of skin basal cell carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › integumentary system disorder › integumentary system cancer › skin cancer › skin carcinoma › skin basal cell carcinoma › morpheaform basal cell carcinoma

Related subtypes (24): penis basal cell carcinoma, scrotum basal cell carcinoma, nodular basal cell carcinoma, metatypical basal cell carcinoma, skin pigmented basal cell carcinoma, anal margin basal cell carcinoma, sebaceous basal cell carcinoma, external ear basal cell carcinoma, micronodular basal cell carcinoma, adamantinoid basal cell epithelioma, skin fibroepithelial basal cell carcinoma, skin clear cell basal cell carcinoma, skin adenoid basal cell carcinoma, follicular basal cell carcinoma, skin infiltrative basal cell carcinoma, superficial multifocal basal cell carcinoma, vulva basal cell carcinoma, skin cystic basal cell carcinoma, sarcomatoid basal cell carcinoma, signet ring basal cell carcinoma, basosquamous carcinoma, salivary gland basal cell adenocarcinoma, infundibulocystic basal cell carcinoma, follicular atrophoderma-basal cell carcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
PHASE3	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT07311070	PHASE3	ENROLLING_BY_INVITATION	Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue